HomeNewsWorldChina hits back at South Korea, Japan in first Covid retaliation

China hits back at South Korea, Japan in first Covid retaliation

Chinese consulates in South Korea will stop issuing short-term visas for visits, business, tourism, medical care, transit and personal matters from Tuesday, the Chinese Embassy in Seoul said in a statement.

January 10, 2023 / 13:21 IST
Story continues below Advertisement
The Chinese national flag flutters in central Beijing.
The Chinese national flag flutters in central Beijing.

China has suspended issuing some visas for South Korea and Japan in Beijing’s first retaliation against Covid-related curbs on Chinese travelers.

Chinese consulates in South Korea will stop issuing short-term visas for visits, business, tourism, medical care, transit and personal matters from Tuesday, the Chinese Embassy in Seoul said in a statement. The suspension will be adjusted if South Korea removes its “discriminative inbound restrictive measures” targeting China, it added.

Story continues below Advertisement

China also suspended visa issuance to Japanese travelers, Kyodo reported, citing unidentified people in the travel industry.

The moves represent China’s first attempt at retaliation after a raft of nations recently implemented testing requirements for travelers from the country. The dismantling of China’s Covid Zero policy after almost three years has sparked a deluge of infections that, combined with a lack of information about how many people are sick or dying, has raised concerns over the possibility that new virus strains will emerge.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show